Could Gilead Sciences Have an HIV Cure Waiting in the Wings?

Most of the enthusiasm for Gilead Sciences (NASDAQ: GILD) in recent months has focused on the antiviral drug Remdesivir. Gilead was also in the headlines last week after reports surfaced that the large pharmaceutical company AstraZeneca was interested in taking over the biotechnology. Could Gilead Sciences have an HIV cure ready?

Click to receive the most important news as a notification!

Last News

Doctor Who villains the Daleks get new look for holiday special

Inside a $49 Million Townhouse in London’s Most Desirable Neighborhood

Former House Republican flips central California seat

A-Rod Kisses J.Lo in a Sweet Family Photo for Thanksgiving 2020

Top 10 Stocks Warren Buffett Just Bought

Amazon Has Over 81,000 Black Friday Deals This Year — Here Are the Best 72